Nakamura, Y.; Horie, I.; Yano, H.; Nomoto, H.; Fukui, T.; Yuyama, Y.; Kawamura, T.; Ueda, M.; Yamamoto, A.; Hirota, Y.;
et al. Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD). Biomedicines 2025, 13, 1287.
https://doi.org/10.3390/biomedicines13061287
AMA Style
Nakamura Y, Horie I, Yano H, Nomoto H, Fukui T, Yuyama Y, Kawamura T, Ueda M, Yamamoto A, Hirota Y,
et al. Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD). Biomedicines. 2025; 13(6):1287.
https://doi.org/10.3390/biomedicines13061287
Chicago/Turabian Style
Nakamura, Yuta, Ichiro Horie, Hiroshi Yano, Hiroshi Nomoto, Tomoyasu Fukui, Yoshihiko Yuyama, Tomoyuki Kawamura, Mariko Ueda, Akane Yamamoto, Yushi Hirota,
and et al. 2025. "Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD)" Biomedicines 13, no. 6: 1287.
https://doi.org/10.3390/biomedicines13061287
APA Style
Nakamura, Y., Horie, I., Yano, H., Nomoto, H., Fukui, T., Yuyama, Y., Kawamura, T., Ueda, M., Yamamoto, A., Hirota, Y., Kusunoki, Y., Nishida, K., Sekiguchi, D., Maeda, Y., Minami, M., Nagayama, A., Iwata, S., Minagawa, H., Furukawa, S.,
... Abiru, N., on behalf of the IPRA-CKD Study Group.
(2025). Adjunct Therapy with Ipragliflozin Exerts Limited Effects on Kidney Protection in Type 1 Diabetes: A Retrospective Study Conducted at 25 Centers in Japan (IPRA-CKD). Biomedicines, 13(6), 1287.
https://doi.org/10.3390/biomedicines13061287
